According to Altimmune's latest financial reports the company's current earnings (TTM) are -โน8.51 B. In 2023 the company made an earning of -โน7.43 B a decrease over its 2022 earnings that were of -โน7.13 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.